1. Home
  2. CHR vs GRI Comparison

CHR vs GRI Comparison

Compare CHR & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CHR

Cheer Holding Inc.

N/A

Current Price

$1.27

Market Cap

3.2M

Sector

Technology

ML Signal

N/A

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

N/A

Current Price

$1.79

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHR
GRI
Founded
2016
2018
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
3.0M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
CHR
GRI
Price
$1.27
$1.79
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $18.50
AVG Volume (30 Days)
16.5K
★ 38.3K
Earning Date
07-28-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.06
N/A
Revenue
N/A
N/A
Revenue This Year
$105.44
N/A
Revenue Next Year
$30.02
N/A
P/E Ratio
$21.98
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.03
$0.18
52 Week High
$2.95
$64.12

Technical Indicators

Market Signals
Indicator
CHR
GRI
Relative Strength Index (RSI) 41.04 52.86
Support Level $1.15 $1.71
Resistance Level $1.73 $2.66
Average True Range (ATR) 0.13 0.17
MACD 0.01 0.04
Stochastic Oscillator 25.00 62.01

Price Performance

Historical Comparison
CHR
GRI

About CHR Cheer Holding Inc.

Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

Share on Social Networks: